Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03134131
Title Expanded Access Program for ONC201 to Treat Recurrent Histone H3 Mutant Glioma
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Oncoceutics, Inc.
Indications

high grade glioma

Therapies

ONC201

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Oncoceutics Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field